Page last updated: 2024-09-05

bilastine and Autoimmune Urticaria

bilastine has been researched along with Autoimmune Urticaria in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's5 (100.00)2.80

Authors

AuthorsStudies
Abdallah, SY; Abdelhaleem, IA; Abdelshafy, AM; Ali, ST; Hassan, AF; Kamal, NM; Mohamed, HA1
Deng, Z; Fan, Z; Kong, D; Li, N; Liu, W; Tu, H; Wang, Q; Xue, X; Yang, X1
Fukunaga, A; Hide, M; Kakei, Y; Nishigori, C; Oda, Y; Omori, T; Washio, K1
Biswas, D; Chowdhury, SN; Das, A; Ghosh, S; Podder, I; Sengupta, S1
Barkate, H; De, A; Deshmukh, G; Dhoot, D; Kochhar, AM; Sarda, A; Shah, B1

Reviews

2 review(s) available for bilastine and Autoimmune Urticaria

ArticleYear
The Impact of Bilastine on Symptoms of Allergic Rhinitis and Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    American journal of rhinology & allergy, 2022, Volume: 36, Issue:5

    Topics: Benzimidazoles; Chronic Urticaria; Histamine Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Randomized Controlled Trials as Topic; Rhinitis, Allergic; Urticaria

2022
Effect of Bilastine on Chronic Urticaria: A Systematic Review and Meta-Analysis.
    International archives of allergy and immunology, 2023, Volume: 184, Issue:2

    Topics: Chronic Urticaria; Humans; Quality of Life; Urticaria

2023

Trials

2 trial(s) available for bilastine and Autoimmune Urticaria

ArticleYear
Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.
    Trials, 2020, Jan-06, Volume: 21, Issue:1

    Topics: Adult; Benzimidazoles; Chronic Urticaria; Dose-Response Relationship, Drug; Drug Substitution; Equivalence Trials as Topic; Histamine H1 Antagonists; Humans; Japan; Multicenter Studies as Topic; Piperidines; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome

2020
Effectiveness, safety, and tolerability of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic spontaneous urticaria: A double-blind, parallel group, randomized controlled trial.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Double-Blind Method; Histamine H1 Antagonists, Non-Sedating; Humans; Piperidines; Quality of Life; Treatment Outcome; Urticaria

2020

Other Studies

1 other study(ies) available for bilastine and Autoimmune Urticaria

ArticleYear
Effect of bilastine on chronic spontaneous urticaria refractory to levocetrizine: Real world experience in India.
    Dermatologic therapy, 2021, Volume: 34, Issue:1

    Topics: Benzimidazoles; Cetirizine; Chronic Disease; Chronic Urticaria; Humans; India; Piperidines; Urticaria

2021